Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr 14;11(4):e0153843.
doi: 10.1371/journal.pone.0153843. eCollection 2016.

A Normative Model of Serum Inhibin B in Young Males

Affiliations

A Normative Model of Serum Inhibin B in Young Males

Thomas W Kelsey et al. PLoS One. .

Abstract

Inhibin B has been identified as a potential marker of Sertoli cell function in males. The aim of this study is to produce a normative model of serum inhibin B in males from birth to seventeen years. We used a well-defined search strategy to identify studies containing data that can contribute to a larger approximation of the healthy population. We combined data from four published studies (n = 709) and derived an internally validated model with high goodness-of-fit and normally distributed residuals. Our results show that inhibin B increases following birth to a post-natal peak of 270 pg/mL (IQR 210-335 pg/mL) and then decreases during childhood followed by a rise at around 8 years, peaking at a mean 305 pg/mL (IQR 240-445 pg/mL) at around age 17. Following this peak there is a slow decline to the standard mature adult normal range of 170 pg/mL (IQR 125-215 pg/mL). This normative model suggests that 35% of the variation in Inhibin B levels in young males is due to age alone, provides an age-specific reference range for inhibin B in the young healthy male population, and will be a powerful tool in evaluating the potential of inhibin B as a marker of Sertoli cell function in pre-pubertal boys.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Root transformed Inhibin B levels.
The red line is the model that best fits the 709 data points, which are indicated by blue squares. The model has r2 = 0.35, indicating that 35% of the variation in inhibin B levels in young males is due to age alone. The green lines represent the upper and lower 95% confidence limits for the predicted mean and the orange lines the upper and lower 95% prediction limits.
Fig 2
Fig 2. Model residuals.
The residuals are the variations in root-adjusted observed values from the root-adjusted age-related mean value predicted by the model. The residuals have 97% goodness of fit to an ideal Gaussian curve.
Fig 3
Fig 3. The Normative Model.
Inhibin B levels in human males from birth to age 17 years expressed as standard centiles.

Similar articles

Cited by

References

    1. Anderson RA, Sharpe RM. Regulation of inhibin production in the human male and its clinical applications. International journal of andrology. 2000;23(3):136–44. - PubMed
    1. Rey RA, Grinspon RP, Gottlieb S, Pasqualini T, Knoblovits P, Aszpis S, et al. Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach. Andrology. 2013;1(1):3–16. 10.1111/j.2047-2927.2012.00008.x - DOI - PubMed
    1. Griswold MD. The central role of Sertoli cells in spermatogenesis. Semin Cell Dev Biol. 1998;9(4):411–6. 10.1006/scdb.1998.0203 - DOI - PubMed
    1. Andersson AM, Juul A, Petersen JH, Muller J, Groome NP, Skakkebaek NE. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. The Journal of clinical endocrinology and metabolism. 1997;82(12):3976–81. 10.1210/jcem.82.12.4449 - DOI - PubMed
    1. Barbotin AL, Ballot C, Sigala J, Ramdane N, Duhamel A, Marcelli F, et al. The serum inhibin B concentration and reference ranges in normozoospermia. European journal of endocrinology / European Federation of Endocrine Societies. 2015;172(6):669–76. 10.1530/EJE-14-0932 - DOI - PubMed

Publication types

LinkOut - more resources